Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME): A Randomized Pilot Study

NCT07844603 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT07844603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07844603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME): A Randomized Pilot Study
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Completed
Start date
September 2, 2025
Completion date
July 13, 2026
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke